Prevalence of Gaucher disease in patients with unknown cause of splenomegaly and/ or thrombocytopenia in Saudi Arabia

Background: Many uncommon metabolic disorders have a high prevalence in Arab countries due to the high rate of consanguineous marriages. This study aimed to assess the prevalence of Gaucher disease (GD) in patients with splenomegaly and/or thrombocytopenia of unknown cause in Saudi Arabia. Methods:...

Full description

Saved in:
Bibliographic Details
Main Authors: Hussain H. Al Saeed, Fahad Alabbas, Ghaleb Elyamany, Abdulrahman Alshehri, Ahmed M. Al-Suliman, Ohoud F. kashari, Anees Malik, Binyam Usman, Maha Sallam, Insherah Barnawi, Ibrahim S. Ghita, Hassan Masmali, Ayman Alhejazi
Format: Article
Language:English
Published: Discover STM Publishing Ltd 2024-02-01
Series:Journal of Biochemical and Clinical Genetics
Subjects:
Online Access:https://www.jbcgenetics.com/?mno=148648
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850208902383140864
author Hussain H. Al Saeed
Fahad Alabbas
Ghaleb Elyamany
Abdulrahman Alshehri
Ahmed M. Al-Suliman
Ohoud F. kashari
Anees Malik
Binyam Usman
Maha Sallam
Insherah Barnawi
Ibrahim S. Ghita
Hassan Masmali
Ayman Alhejazi
author_facet Hussain H. Al Saeed
Fahad Alabbas
Ghaleb Elyamany
Abdulrahman Alshehri
Ahmed M. Al-Suliman
Ohoud F. kashari
Anees Malik
Binyam Usman
Maha Sallam
Insherah Barnawi
Ibrahim S. Ghita
Hassan Masmali
Ayman Alhejazi
author_sort Hussain H. Al Saeed
collection DOAJ
description Background: Many uncommon metabolic disorders have a high prevalence in Arab countries due to the high rate of consanguineous marriages. This study aimed to assess the prevalence of Gaucher disease (GD) in patients with splenomegaly and/or thrombocytopenia of unknown cause in Saudi Arabia. Methods: This screening study was conducted in 13 hematology and hematopathology centers in Saudi Arabia over 2 years. Patients with splenomegaly and/or thrombocytopenia of unknown cause for at least a year were included. Enzyme activity in eligible patients was assessed using a dried blood spot sample. Results: Out of 390 patients, 87.4% had thrombocytopenia. In comparison, 8.8% had a history of splenectomy, and nearly 67.7% had splenomegaly. Fatigue, bone crises, and abdominal pain were commonly reported among adult patients. Anemia was the most common symptom among pediatric patients, followed by splenomegaly and easy bruising or bleeding. One patient was found to have GD. She was a Saudi toddler with no family history of GD, acid sphingomyelinase deficiency, or other genetic abnormalities. The GD patient's neurological, cardiac, and skeletal examinations were normal. Conclusion: This screening study paves the way for GD screening in Saudi Arabia. It also emphasizes the importance of early diagnosis, proper care, and positive outcomes for GD. [JBCGenetics 2024; 7(1.000): 003-011]
format Article
id doaj-art-065fa635d3384b6e9a9cd1b3e0ed95b3
institution OA Journals
issn 1658-807X
1658-8088
language English
publishDate 2024-02-01
publisher Discover STM Publishing Ltd
record_format Article
series Journal of Biochemical and Clinical Genetics
spelling doaj-art-065fa635d3384b6e9a9cd1b3e0ed95b32025-08-20T02:10:08ZengDiscover STM Publishing LtdJournal of Biochemical and Clinical Genetics1658-807X1658-80882024-02-017100301110.24911/JBCGenetics.183-1680730821148648Prevalence of Gaucher disease in patients with unknown cause of splenomegaly and/ or thrombocytopenia in Saudi ArabiaHussain H. Al Saeed0Fahad Alabbas1Ghaleb Elyamany2Abdulrahman Alshehri3Ahmed M. Al-Suliman4Ohoud F. kashari5Anees Malik6Binyam Usman7Maha Sallam8Insherah Barnawi9Ibrahim S. Ghita10Hassan Masmali11Ayman Alhejazi12Department of Medicine, Qatif Central Hospital, Qatif, Saudi Arabia Department of Pediatrics, Hematology and Oncology Division, Prince Sultan Military Medical City, Riyadh, Saudi Arabia Department of Pathology and Laboratory Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia Department of Hematology and Oncology, Asir Central Hospital, Abha, Saudi Arabia. Medical Department, Prince Saud Bin Jalawy Hospital, Hofuf, Saudi Arabia Department of Hematology, Al Aziziyah children hospital, Jeddah, Saudi Arabia Department of Medicine, Ministry of National Guard Health Affairs, King Saud Bin AbdulAziz University for Health Sciences, King Abdullah International Medical Research Centre, Saudi Arabia Department of Oncology, King Faisal Specialist Hospital, Jeddah, Saudi Arabia Head of hematopathology and coagulopathy unit, King Fahd Hospital, Hofuf, Saudi Arabia Hematology Department, King Fahd Hospital, Medina, Saudi Arabia Department of Adult Hematology, Al Noor Specialist hospital, Mecca, Saudi Arabia Department of Pediatric, Maternity and Children Hospital, Mecca, Saudi Arabia King Saud bin Abdulaziz University for Health Sciences, Division of Adult Hematology, National Guard - Health Affairs, Riyadh, Saudi Arabia.Background: Many uncommon metabolic disorders have a high prevalence in Arab countries due to the high rate of consanguineous marriages. This study aimed to assess the prevalence of Gaucher disease (GD) in patients with splenomegaly and/or thrombocytopenia of unknown cause in Saudi Arabia. Methods: This screening study was conducted in 13 hematology and hematopathology centers in Saudi Arabia over 2 years. Patients with splenomegaly and/or thrombocytopenia of unknown cause for at least a year were included. Enzyme activity in eligible patients was assessed using a dried blood spot sample. Results: Out of 390 patients, 87.4% had thrombocytopenia. In comparison, 8.8% had a history of splenectomy, and nearly 67.7% had splenomegaly. Fatigue, bone crises, and abdominal pain were commonly reported among adult patients. Anemia was the most common symptom among pediatric patients, followed by splenomegaly and easy bruising or bleeding. One patient was found to have GD. She was a Saudi toddler with no family history of GD, acid sphingomyelinase deficiency, or other genetic abnormalities. The GD patient's neurological, cardiac, and skeletal examinations were normal. Conclusion: This screening study paves the way for GD screening in Saudi Arabia. It also emphasizes the importance of early diagnosis, proper care, and positive outcomes for GD. [JBCGenetics 2024; 7(1.000): 003-011]https://www.jbcgenetics.com/?mno=148648gaucher diseasesplenomegalythrombocytopeniasaudi arabia
spellingShingle Hussain H. Al Saeed
Fahad Alabbas
Ghaleb Elyamany
Abdulrahman Alshehri
Ahmed M. Al-Suliman
Ohoud F. kashari
Anees Malik
Binyam Usman
Maha Sallam
Insherah Barnawi
Ibrahim S. Ghita
Hassan Masmali
Ayman Alhejazi
Prevalence of Gaucher disease in patients with unknown cause of splenomegaly and/ or thrombocytopenia in Saudi Arabia
Journal of Biochemical and Clinical Genetics
gaucher disease
splenomegaly
thrombocytopenia
saudi arabia
title Prevalence of Gaucher disease in patients with unknown cause of splenomegaly and/ or thrombocytopenia in Saudi Arabia
title_full Prevalence of Gaucher disease in patients with unknown cause of splenomegaly and/ or thrombocytopenia in Saudi Arabia
title_fullStr Prevalence of Gaucher disease in patients with unknown cause of splenomegaly and/ or thrombocytopenia in Saudi Arabia
title_full_unstemmed Prevalence of Gaucher disease in patients with unknown cause of splenomegaly and/ or thrombocytopenia in Saudi Arabia
title_short Prevalence of Gaucher disease in patients with unknown cause of splenomegaly and/ or thrombocytopenia in Saudi Arabia
title_sort prevalence of gaucher disease in patients with unknown cause of splenomegaly and or thrombocytopenia in saudi arabia
topic gaucher disease
splenomegaly
thrombocytopenia
saudi arabia
url https://www.jbcgenetics.com/?mno=148648
work_keys_str_mv AT hussainhalsaeed prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT fahadalabbas prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT ghalebelyamany prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT abdulrahmanalshehri prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT ahmedmalsuliman prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT ohoudfkashari prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT aneesmalik prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT binyamusman prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT mahasallam prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT insherahbarnawi prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT ibrahimsghita prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT hassanmasmali prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia
AT aymanalhejazi prevalenceofgaucherdiseaseinpatientswithunknowncauseofsplenomegalyandorthrombocytopeniainsaudiarabia